Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-03-11

Clinical Trial Update: Study of Glaucoma Treatment With Food Additives [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the use of food additives for treating glaucoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Unspecified food additives for glaucoma treatment

Snippet

Sponsor: Future Products Management | Conditions: Glaucomatous Neuropathy | Phase 1, Phase 2 | Status: TERMINATED